[1] Mathes EF, Haggstrom AN, Dowd C, et al. Clinical characteristics and management of vascular anomalies: findings of a multidisciplinary vascular anomalies clinic [J]. Arch Dermatol, 2004, 140(8): 979-983. [2] 张志愿, 王延安, 郑家伟, 等. 头颈部脉管性疾病的诊断与治疗[J]. 上海交通大学学报(医学版), 2012, 32(9): 1258-1263. [3] Saito N, Sasaki S, Sekido M, et al. Efficacy of polidocanol sclerotherapy for capillary malformation with masked venous malformation [J]. Dermatol Surg, 2009, 35(1): 161-164. [4] Blaise S, Charavin-Cocuzza M, Riom H, et al. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review[J]. Eur J Vasc Endovasc Surg, 2011, 41(3): 412-417. [5] Yamaki T, Nozaki M, lwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency [J]. Dermatol Surg, 2004, 30(5): 718-722. [6] Uncu H. Sclerotherapy: a study comparing polidocanol in foam and liquid form [J]. Phlebology, 2010, 25(1): 44-49. [7] Orbach EJ, Petretti AK. The thrombogenic property of foam of a synthetic anionic detergent [J]. Angeology, 1950, 1(3): 237-243. [8] Yamaki T, Nozaki M, Sakurai H, et al. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations[J]. J Vasc Surg, 2008, 47(3): 578-584. [9] Wolmann JC. Sclerosant foams: Stabilities, physical properties |